Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases
Open Access
- 13 May 2009
- journal article
- review article
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 7 (1) , 9
Abstract
The purpose of this study is to compare the incidence of congenital defects, spontaneous abortions, number of live births, fetal death and pre-maturity in women with autoimmune diseases taking HCQ during pregnancy. The authors searched MEDLINE, Cochrane data base, Ovid-Currents Clinical Medicine, Ovid-Embase:Drugs and Pharmacology, EBSCO, Web of Science, and SCOPUS using the search terms HCQ and/or pregnancy. We attempted to identify all clinical trials from 1980 to 2007 regardless of language or publication status. We also searched Cochrane Central Library and http://www.Clinical trials.gov for clinical trials of HCQ and pregnancy. Data were extracted onto standardized forms and were confirmed. The odds ratio (OR) of congenital defects in live births of women taking HCQ during pregnancy was 0.66, 95% confidence intervals (CI) 0.25, 1.75. The OR of a live birth for women taking HCQ during pregnancy was 1.05 (95% CI 0.58, 1.93). The OR of spontaneous abortion in women taking HCQ during pregnancy was 0.92 (95% CI 0.49, 1.72). The OR of fetal deaths in women taking HCQ during pregnancy was 0.97 (95% CI 0.14, 6.54). The OR of pre-mature birth defined as birth before 37 weeks in women taking HCQ during pregnancy was 1.10 (95% CI 0.75, 1.61). HCQ is not associated with any increased risk of congenital defects, spontaneous abortions, fetal death, pre-maturity and decreased numbers of live births in patients with auto-immune diseases.Keywords
This publication has 44 references indexed in Scilit:
- Ocular Adverse Effects Associated with Systemic MedicationsDrugs, 2007
- Drugs for preventing malaria in pregnant women2006
- Disease-Modifying Antirheumatic Drugs in PregnancyDrug Safety, 2006
- A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpointsStatistics in Medicine, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled studyLupus, 2001
- Surveying Physicians To Determine the Minimal Important DifferenceJournal of Clinical Epidemiology, 1999
- Pregnancy Outcome Following First Trimester Exposure to ChloroquineAmerican Journal of Perinatology, 1991
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Accumulation of Chorio-retinotoxic Drugs in the Foetal EyeNature, 1970